Table of Contents Author Guidelines Submit a Manuscript
Malaria Research and Treatment
Volume 2017, Article ID 6429410, 13 pages
https://doi.org/10.1155/2017/6429410
Review Article

Bibliometric Analysis of Worldwide Publications on Antimalarial Drug Resistance (2006–2015)

1Department of Physiology, Pharmacology and Toxicology, College of Medicine and Health Sciences, An-Najah National University, Nablus, State of Palestine
2Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, State of Palestine

Correspondence should be addressed to Ansam F. Sawalha; ude.hajan@masna

Received 28 March 2017; Revised 28 April 2017; Accepted 10 July 2017; Published 10 August 2017

Academic Editor: Sasithon Pukrittayakamee

Copyright © 2017 Waleed M. Sweileh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. L. Alonso and M. Tanner, “Public health challenges and prospects for malaria control and elimination,” Nature Medicine, vol. 19, no. 2, pp. 150–155, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. World Health Organization, Fact Sheet: World Malaria Report 2015, 2015, http://www.who.int/malaria/media/world-malaria-report-2015/en/.
  3. C. J. Murray, K. F. Ortblad, C. Guinovart et al. et al., “Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013,” Lancet, vol. 384, no. 9947, pp. 1005–1070, 2014. View at Google Scholar
  4. N. J. White, S. Pukrittayakamee, and T. T. Hien, “Malaria,” The Lancet, vol. 383, no. 9918, pp. 723–735, 2013. View at Publisher · View at Google Scholar
  5. L. H. Miller, H. C. Ackerman, X.-Z. Su, and T. E. Wellems, “Malaria biology and disease pathogenesis: insights for new treatments,” Nature Medicine, vol. 19, no. 2, pp. 156–167, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Dasari and S. Bhakdi, “Pathogenesis of malaria revisited,” Medical Microbiology and Immunology, vol. 201, no. 4, pp. 599–604, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. United Nations (UN), Millennium Development Goals and Beyond, 2015, http://www.un.org/millenniumgoals/aids.shtml.
  8. N. J. White, “Declining malaria transmission and pregnancy outcomes in southern Mozambique,” New England Journal of Medicine, vol. 373, no. 17, pp. 1670-1671, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. A. della Torre, B. Arca, G. Favia, V. Petrarca, and M. Coluzzi, “The role of research in molecular entomology in the fight against malaria vectors.,” Parassitologia, vol. 50, no. 1-2, pp. 137–140, 2008. View at Google Scholar · View at Scopus
  10. J. Hemingway, “The role of vector control in stopping the transmission of malaria: threats and opportunities,” Philosophical transactions of the Royal Society of London. Series B, Biological sciences, vol. 369, no. 1645, p. 20130431, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Lal, C. Lahariya, and V. K. Saxena, “Insecticide treated nets, antimalarials and child survival in India,” Indian Journal of Pediatrics, vol. 77, no. 4, pp. 425–430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. G. D. Zhu, J. Cao, H. Y. Zhou, and Q. Gao, “[Research progress on malaria vector control],” Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, vol. 25, no. 3, pp. 312–315, 2013. View at Google Scholar
  13. E. Hempelmann, I. Tesarowicz, and B. J. Oleksyn, “Concise history of malaria chemotherapy: From onions to artemisinin,” Pharmazie in Unserer Zeit, vol. 38, no. 6, pp. 500–507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. N. J. White, “Assessment of the pharmacodynamic properties of antimalarial drugs in vivo,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 7, pp. 1413–1422, 1997. View at Google Scholar · View at Scopus
  15. G. Brown, “Artemisinin and a new generation of antimalarial drugs,” Education in Chemistry, vol. 43, no. 4, pp. 97–99, 2006. View at Google Scholar · View at Scopus
  16. Z. Guo, “Artemisinin anti-malarial drugs in China,” Acta Pharmaceutica Sinica B, vol. 6, no. 2, pp. 115–124, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Callaway and D. Cyranoski, “Anti-parasite drugs sweep Nobel prize in medicine 2015,” Nature, vol. 526, no. 7572, pp. 174-175, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. D. L. Klayman, “Qinghaosu (Artemisinin): An antimalarial drug from China,” Science, vol. 228, no. 4703, pp. 1049–1055, 1985. View at Publisher · View at Google Scholar · View at Scopus
  19. C. H. Sibley and R. N. Price, “Monitoring antimalarial drug resistance: applying lessons learned from the past in a fast-moving present,” International Journal for Parasitology: Drugs and Drug Resistance, vol. 2, pp. 126–133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Cui, S. Mharakurwa, D. Ndiaye, P. K. Rathod, and P. J. Rosenthal, “Antimalarial drug resistance: Literature review and activities and findings of the ICEMR network,” American Journal of Tropical Medicine and Hygiene, vol. 93, pp. 57–68, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Ecker, A. M. Lehane, J. Clain, and D. A. Fidock, “PfCRT and its role in antimalarial drug resistance,” Trends in Parasitology, vol. 28, no. 11, pp. 504–514, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. E. A. Winzeler and M. J. Manary, “Drug resistance genomics of the antimalarial drug artemisinin,” Genome Biology, vol. 15, no. 11, article no. 544, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Fu, T. Hu, J. Wang et al., “A bibliometric analysis of malaria research in China during 2004-2014,” Malaria Journal, vol. 14, no. 1, article no. 195, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. K. C. Garg, S. Kumar, Y. Madhavi, and M. Bahl, “Bibliometrics of global malaria vaccine research,” Health Information and Libraries Journal, vol. 26, no. 1, pp. 22–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. B. M. Gupta and A. Bala, “A bibliometric analysis of malaria research in India during 1998-2009,” Journal of Vector Borne Diseases, vol. 48, no. 3, pp. 163–170, 2011. View at Google Scholar · View at Scopus
  26. G. Lewison, S. Lipworth, and A. De Francisco, “Input indicators from output measures: A bibliometric approach to the estimation of malaria research funding,” Research Evaluation, vol. 11, no. 3, pp. 155–163, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. R. K. Maharana, “Malaria research in India during 2003-2012: A bibliometric analysis,” Collection Building, vol. 33, no. 2, pp. 53–59, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Munoz-Urbano, A. F. Lopez-Isaza, N. Hurtado-Hurtado et al., “Scientific research in malaria: bibliometric assessment of the Latin-American contributions,” Recent patents on anti-infective drug discovery, vol. 9, no. 3, pp. 209–215, 2014. View at Google Scholar · View at Scopus
  29. A. M. Van Eijk, J. Hill, S. Povall, A. Reynolds, H. Wong, and F. O. Ter Kuile, “The Malaria in Pregnancy Library: A bibliometric review,” Malaria Journal, vol. 11, article no. 362, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. H. Zyoud, S. W. Al-Jabi, W. M. Sweileh, and R. Awang, “A bibliometric analysis of toxicology research productivity in Middle Eastern Arab countries during a 10-year period (2003-2012),” Health Research Policy and Systems, vol. 12, no. 1, article no. 4, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. H. Zyoud, S. W. Al-Jabi, and W. M. Sweileh, “Worldwide research productivity of paracetamol (acetaminophen) poisoning: A bibliometric analysis (2003-2012),” Human and Experimental Toxicology, vol. 34, no. 1, pp. 12–23, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. S. H. Zyoud, S. W. Al-Jabi, W. M. Sweileh, and R. Awang, “A bibliometric analysis of research productivity of Malaysian publications in leading toxicology journals during a 10-year period (2003-2012),” Human and Experimental Toxicology, vol. 33, no. 12, pp. 1284–1293, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. S. H. Zyoud, S. W. Al-Jabi, W. M. Sweileh, and W. S. Waring, “Scientific research related to calcium channel blockers poisoning,” Human and Experimental Toxicology, vol. 34, no. 11, pp. 1162–1170, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. W. M. Sweileh, S. W. Al-Jabi, A. F. Sawalha, and S. H. Zyoud, “Bibliometric profile of the global scientific research on autism spectrum disorders,” SpringerPlus, vol. 5, no. 1, article no. 1480, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. W. M. Sweileh, N. Y. Shraim, S. W. Al-Jabi et al., “Assessing worldwide research activity on probiotics in pediatrics using Scopus database: 1994-2014,” World Allergy Organization Journal, vol. 9, no. 1, article no. 25, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. W. M. Sweileh, S. H. Zyoud, S. W. Al-Jabi, A. F. Sawalha, and N. Y. Shraim, “Drinking and recreational water-related diseases: A bibliometric analysis (1980-2015),” Annals of Occupational and Environmental Medicine, vol. 28, no. 1, article no. 40, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. S. H. Zyoud, S. H. Zyoud, S. W. Al-Jabi, W. M. Sweileh, and R. Awang, “Contribution of Arab countries to pharmaceutical wastewater literature: A bibliometric and comparative analysis of research output,” Annals of Occupational and Environmental Medicine, vol. 28, no. 1, article no. 28, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. S. H. Zyoud, W. S. Waring, S. W. Al-Jabi, W. M. Sweileh, B. Rahhal, and R. Awang, “Intravenous Lipid Emulsion as an Antidote for the Treatment of Acute Poisoning: A Bibliometric Analysis of Human and Animal Studies,” Basic and Clinical Pharmacology and Toxicology, vol. 119, no. 5, pp. 512–519, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. M. E. Falagas, E. I. Pitsouni, G. A. Malietzis, and G. Pappas, “Comparison of PubMed, Scopus, Web of Science, and Google Scholar: Strengths and weaknesses,” FASEB Journal, vol. 22, no. 2, pp. 338–342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. N. J. van Eck and L. Waltman, VOSviewer manual, Leiden: Univeristeit Leiden, 2013, http://www.vosviewer.com/documentation/Manual_VOSviewer_1.5.4.pdf. View at Publisher · View at Google Scholar
  41. A. M. Dondorp, F. Nosten, P. Yi et al., “Artemisinin resistance in Plasmodium falciparum malaria,” The New England Journal of Medicine, vol. 361, no. 5, pp. 455–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Noedl, Y. Se, K. Schaecher, B. L. Smith, D. Socheat, and M. M. Fukuda, “Evidence of artemisinin-resistant malaria in Western Cambodia,” The New England Journal of Medicine, vol. 359, pp. 2619-2620, 2008. View at Publisher · View at Google Scholar
  43. A. P. Phyo, S. Nkhoma, K. Stepniewska et al., “Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study,” The Lancet, vol. 379, no. 9830, pp. 1960–1966, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Ariey, B. Witkowski, C. Amaratunga et al., “A molecular marker of artemisinin-resistant Plasmodium falciparum malaria,” Nature, vol. 505, no. 7481, pp. 50–55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Tjitra, N. M. Anstey, P. Sugiarto et al., “Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia,” PLoS Medicine, vol. 5, no. 6, pp. 0890–0899, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. E. A. Ashley, M. Dhorda, R. M. Fairhurst et al. et al., “Spread of artemisinin resistance in Plasmodium falciparum malaria,” New England Journal of Medicine, vol. 371, no. 5, pp. 411–423, 2014. View at Google Scholar
  47. R. N. Price, N. M. Douglas, and N. M. Anstey, “New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance,” Current Opinion in Infectious Diseases, vol. 22, no. 5, pp. 430–435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. I. H. Cheeseman, B. A. Miller, S. Nair et al., “A major genome region underlying artemisinin resistance in malaria,” Science, vol. 335, no. 6077, pp. 79–82, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. F. O. Ter Kuile, A. M. van Eijk, and S. J. Filler, “Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review,” The Journal of the American Medical Association, vol. 297, no. 23, pp. 2603–2616, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. R. N. Price, A.-C. Uhlemann, M. van Vugt et al., “Molecular and pharmacological determinants of the therapeutic response to artemether-lumefentrine in multidrug-resistant Plasmodium falciparum malaria,” Clinical Infectious Diseases, vol. 42, no. 11, pp. 1570–1577, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. R. M. Packard, “The origins of antimalarial-drug resistance,” New England Journal of Medicine, vol. 371, no. 5, pp. 397–399, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Marsh, “Malaria disaster in Africa,” Lancet, vol. 352, no. 9132, p. 924, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. E. L. Korenromp, B. G. Williams, E. Gouws, C. Dye, and R. W. Snow, “Measurement of trends in childhood malaria mortality in Africa: An assessment of progress toward targets based on verbal autopsy,” Lancet Infectious Diseases, vol. 3, no. 6, pp. 349–358, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. D. F. Clyde and G. T. Shute, “Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 51, no. 6, pp. 505–513, 1957. View at Publisher · View at Google Scholar · View at Scopus
  55. I. Petersen, R. Eastman, and M. Lanzer, “Drug-resistant malaria: molecular mechanisms and implications for public health,” FEBS Letters, vol. 585, no. 11, pp. 1551–1562, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. M. A. Travassos and M. K. Laufer, “Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations,” Pediatric Research, vol. 65, no. 5, article 2, pp. 64R–70R, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Nzila, E. Ochong, E. Nduati et al., “Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 99, no. 5, pp. 341–346, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. J. C. Wootton, X. Feng, M. T. Ferdig et al., “Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum,” Nature, vol. 418, no. 6895, pp. 320–323, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. T. E. Wellems and C. V. Plowe, “Chloroquine-resistant malaria,” Journal of Infectious Diseases, vol. 184, no. 6, pp. 770–776, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. J. G. Kublin, J. F. Cortese, E. M. Njunju et al., “Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi,” Journal of Infectious Diseases, vol. 187, no. 12, pp. 1870–1875, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. M. D. Spring, J. T. Lin, J. E. Manning et al., “Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: An observational cohort study,” The Lancet Infectious Diseases, vol. 15, no. 6, pp. 683–691, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Leang, A. Barrette, D. M. Bouth et al., “Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated plasmodium falciparum and plasmodium vivax in Cambodia, 2008 to 2010,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 2, pp. 818–826, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. B. Witkowski, V. Duru, N. Khim et al., “A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study,” The Lancet Infectious Diseases, vol. 17, no. 2, pp. 174–183, 2017. View at Publisher · View at Google Scholar · View at Scopus
  64. S.-M. Zhao and M.-Y. Wang, “Artemisinin resistance in Plasmodium falciparum: global status and basic research,” Chinese journal of parasitology & parasitic diseases, vol. 32, no. 5, pp. 380–384, 2014. View at Google Scholar · View at Scopus
  65. R. M. Fairhurst, G. M. L. Nayyar, J. G. Breman et al., “Artemisinin-resistant malaria: research challenges, opportunities, and public health implications,” The American Journal of Tropical Medicine and Hygiene, vol. 87, no. 2, pp. 231–241, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. T. Mita and K. Tanabe, “Evolution of Plasmodium falciparum drug resistance: Implications for the development and containment of artemisinin resistance,” Japanese Journal of Infectious Diseases, vol. 65, no. 6, pp. 465–475, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. C. O'Brien, P. P. Henrich, N. Passi, and D. A. Fidock, “Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum,” Current Opinion in Infectious Diseases, vol. 24, no. 6, pp. 570–577, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. C. Wongsrichanalai and C. H. Sibley, “Fighting drug-resistant Plasmodium falciparum: The challenge of artemisinin resistance,” Clinical Microbiology and Infection, vol. 19, no. 10, pp. 908–916, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. L. R. Johnson, K. D. Lafferty, A. McNally et al., “Mapping the Distribution of Malaria: Current Approaches and Future Directions,” in Analyzing and Modeling Spatial and Temporal Dynamics of Infectious Diseases, D. Chen, B. Moulin, and W. J. Hoboken, Eds., pp. 189–209, John Wiley &a Sons, NJ, USA, 2015. View at Google Scholar
  70. H. Noedl, “The need for new antimalarial drugs less prone to resistance,” Current Pharmaceutical Design, vol. 19, no. 2, pp. 266–269, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. World Health Organization, Strategy for malaria elimination in the Greater Mekong Subregion: 2015-2030, 2015, http://iris.wpro.who.int/bitstream/handle/10665.1/10945/9789290617181_eng.pdf?sequence=1.
  72. M. Imwong, T. Jindakhad, C. Kunasol, K. Sutawong, P. Vejakama, and A. M. Dondorp, “An outbreak of artemisinin resistant falciparum malaria in Eastern Thailand,” Scientific Reports, vol. 5, article no. 7412, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Takala-Harrison, C. G. Jacob, and C. Arze, “Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia,” The Journal of Infectious Diseases, vol. 211, no. 5, pp. 670–679, 2015. View at Publisher · View at Google Scholar
  74. R. L. Summers, M. N. Nash, and R. E. Martin, “Know your enemy: Understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics,” Cellular and Molecular Life Sciences, vol. 69, no. 12, pp. 1967–1995, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. E. Pelfrene, M.-H. Pinheiro, and M. Cavaleri, “Artemisinin-based combination therapy in the treatment of uncomplicated malaria: review of recent regulatory experience at the European Medicines Agency,” International Health, vol. 7, no. 4, pp. 239–246, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. World Health Organization, Overview of malaria treatment, 2016, http://www.who.int/malaria/areas/treatment/overview/en/.
  77. A. A. A. Elmannan, K. A. Elmardi, Y. A. Idris, J. M. Spector, N. A. Ali, and E. M. Malik, “Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance,” BMC Pharmacology and Toxicology, vol. 16, no. 1, article no. 3, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Berendes, O. Adeyemi, E. A. Oladele, O. B. Oresanya, F. Okoh, and J. J. Valadez, “Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria,” PLoS ONE, vol. 7, no. 9, Article ID e44775, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. N. Mishra, R. Gupta, S. Singh et al., “Insights following change in drug policy: A descriptive study for antimalarial prescription practices in children of public sector health facilities in Jharkhand state of India,” Journal of Vector Borne Diseases, vol. 50, no. 4, pp. 271–277, 2013. View at Google Scholar · View at Scopus
  80. V. S. Pribluda, L. Evans, E. Barillas, J. Marmion, P. Lukulay, and J. Chang, “Were medicine quality and pharmaceutical management contributing factors in diminishing artemisinin efficacy in Guyana and Suriname?” Malaria Journal, vol. 13, no. 1, article no. 77, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. O. Miotto, J. Almagro-Garcia, M. Manske et al. et al., “Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia,” Nature Genetics, vol. 45, no. 6, pp. 648–655, 2013. View at Google Scholar
  82. E. Talundzic, S. A. Okoth, K. Congpuong et al. et al., “Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign,” PLoS Pathog, vol. 11, no. 4, Article ID e1004789, 2015. View at Google Scholar
  83. W. M. Sweileh, “Global research trends of World Health Organization’s top eight emerging pathogens,” Globalization and Health, vol. 13, no. 1, 2017. View at Publisher · View at Google Scholar
  84. W. M. Sweileh, S. W. Al-Jabi, A. F. Sawalha, A. S. AbuTaha, and S. H. Zyoud, “Bibliometric analysis of publications on Campylobacter: (2000–2015),” Journal of Health, Population and Nutrition, vol. 35, no. 1, 2016. View at Publisher · View at Google Scholar
  85. W. M. Sweileh, S. W. Al-Jabi, A. F. Sawalha, A. S. AbuTaha, and S. H. Zyoud, “Bibliometric analysis of medicine-related publications on poverty (2005–2015),” SpringerPlus, vol. 5, no. 1, article no. 1888, 2016. View at Publisher · View at Google Scholar · View at Scopus
  86. W. M. Sweileh, A. F. Sawalha, S. Al-Jabi, and S. H. Zyoud, “Bibliometric analysis of literature on antifungal triazole resistance: 1980 – 2015,” GERMS, vol. 7, no. 1, pp. 19–27, 2017. View at Publisher · View at Google Scholar
  87. W. M. Sweileh, A. F. Sawalha, S. W. Al-Jabi, S. H. Zyoud, N. Y. Shraim, and A. S. Abu-Taha, “A bibliometric analysis of literature on malaria vector resistance: (1996 - 2015),” Globalization and Health, vol. 12, no. 1, article no. 76, 2016. View at Publisher · View at Google Scholar · View at Scopus
  88. W. M. Sweileh, N. Y. Shraim, S. W. Al-Jabi, A. F. Sawalha, A. S. AbuTaha, and S. H. Zyoud, “Bibliometric analysis of global scientific research on carbapenem resistance (1986-2015),” Annals of Clinical Microbiology and Antimicrobials, vol. 15, no. 1, article no. 56, 2016. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Zyoud, W. Waring, S. Al-Jabi, and W. Sweileh, “Global research production in glyphosate intoxication from 1978 to 2015: A bibliometric analysis,” Human & Experimental Toxicology. View at Publisher · View at Google Scholar
  90. S. H. Zyoud, W. S. Waring, S. W. Al-Jabi, and W. M. Sweileh, “Global cocaine intoxication research trends during 1975–2015: a bibliometric analysis of Web of Science publications,” Substance Abuse Treatment, Prevention, and Policy, vol. 12, no. 1, 2017. View at Publisher · View at Google Scholar